Funding for this research was provided by:
This research was supported by Korea Drug Development Fund funded by Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, and Ministry of Health and Welfare
Article History
Received: 12 December 2019
Accepted: 28 April 2020
First Online: 21 May 2020
Competing interests
: Kyoung Song and Young Kee Shin currently hold stocks of ABION Inc., and Na Young Kim holds its stock options and is salaried employees of Abion Inc., and Young Kee Shin have received consulting fees from the Abion Inc.